276 related articles for article (PubMed ID: 37133566)
1. TREM2 promotes cholesterol uptake and foam cell formation in atherosclerosis.
Guo X; Li B; Wen C; Zhang F; Xiang X; Nie L; Chen J; Mao L
Cell Mol Life Sci; 2023 May; 80(5):137. PubMed ID: 37133566
[TBL] [Abstract][Full Text] [Related]
2. Nicotine potentiates proatherogenic effects of oxLDL by stimulating and upregulating macrophage CD36 signaling.
Zhou MS; Chadipiralla K; Mendez AJ; Jaimes EA; Silverstein RL; Webster K; Raij L
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(4):H563-74. PubMed ID: 23748423
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of macrophage-derived foam cells by Adipsin attenuates progression of atherosclerosis.
Duan Y; Zhang X; Zhang X; Lin J; Shu X; Man W; Jiang M; Zhang Y; Wu D; Zhao Z; Sun D
Biochim Biophys Acta Mol Basis Dis; 2022 Dec; 1868(12):166533. PubMed ID: 36064133
[TBL] [Abstract][Full Text] [Related]
4. Vav Guanine nucleotide exchange factors regulate atherosclerotic lesion development in mice.
Rahaman SO; Li W; Silverstein RL
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2053-7. PubMed ID: 23825362
[TBL] [Abstract][Full Text] [Related]
5. Foam cells in atherosclerosis.
Yu XH; Fu YC; Zhang DW; Yin K; Tang CK
Clin Chim Acta; 2013 Sep; 424():245-52. PubMed ID: 23782937
[TBL] [Abstract][Full Text] [Related]
6. WISP1 alleviates lipid deposition in macrophages via the PPARγ/CD36 pathway in the plaque formation of atherosclerosis.
Liu D; Wang X; Zhang M; Tian J; Liu M; Jin T; Pan J; Gao M; An F
J Cell Mol Med; 2020 Oct; 24(20):11729-11741. PubMed ID: 32851768
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of Orai1 Store-Operated Calcium Channel Prevents Foam Cell Formation and Atherosclerosis.
Liang SJ; Zeng DY; Mai XY; Shang JY; Wu QQ; Yuan JN; Yu BX; Zhou P; Zhang FR; Liu YY; Lv XF; Liu J; Ou JS; Qian JS; Zhou JG
Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):618-28. PubMed ID: 26916730
[TBL] [Abstract][Full Text] [Related]
8. Myeloid LXR (Liver X Receptor) Deficiency Induces Inflammatory Gene Expression in Foamy Macrophages and Accelerates Atherosclerosis.
Endo-Umeda K; Kim E; Thomas DG; Liu W; Dou H; Yalcinkaya M; Abramowicz S; Xiao T; Antonson P; Gustafsson JÅ; Makishima M; Reilly MP; Wang N; Tall AR
Arterioscler Thromb Vasc Biol; 2022 Jun; 42(6):719-731. PubMed ID: 35477277
[TBL] [Abstract][Full Text] [Related]
9. Nucleolin protects macrophages from oxLDL-induced foam cell formation through up-regulating ABCA1 expression.
Li Y; Jiang B; Liang P; Tong Z; Liu M; Lv Q; Liu Y; Liu X; Tang Y; Xiao X
Biochem Biophys Res Commun; 2017 Apr; 486(2):364-371. PubMed ID: 28315324
[TBL] [Abstract][Full Text] [Related]
10. EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E-deficient mice from developing atherosclerotic lesions.
Marleau S; Harb D; Bujold K; Avallone R; Iken K; Wang Y; Demers A; Sirois MG; Febbraio M; Silverstein RL; Tremblay A; Ong H
FASEB J; 2005 Nov; 19(13):1869-71. PubMed ID: 16123174
[TBL] [Abstract][Full Text] [Related]
11. Macrophagic CD146 promotes foam cell formation and retention during atherosclerosis.
Luo Y; Duan H; Qian Y; Feng L; Wu Z; Wang F; Feng J; Yang D; Qin Z; Yan X
Cell Res; 2017 Mar; 27(3):352-372. PubMed ID: 28084332
[TBL] [Abstract][Full Text] [Related]
12. Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice.
Moore KJ; Kunjathoor VV; Koehn SL; Manning JJ; Tseng AA; Silver JM; McKee M; Freeman MW
J Clin Invest; 2005 Aug; 115(8):2192-201. PubMed ID: 16075060
[TBL] [Abstract][Full Text] [Related]
13. A growth hormone-releasing peptide that binds scavenger receptor CD36 and ghrelin receptor up-regulates sterol transporters and cholesterol efflux in macrophages through a peroxisome proliferator-activated receptor gamma-dependent pathway.
Avallone R; Demers A; Rodrigue-Way A; Bujold K; Harb D; Anghel S; Wahli W; Marleau S; Ong H; Tremblay A
Mol Endocrinol; 2006 Dec; 20(12):3165-78. PubMed ID: 16959872
[TBL] [Abstract][Full Text] [Related]
14. Siglec-E retards atherosclerosis by inhibiting CD36-mediated foam cell formation.
Hsu YW; Hsu FF; Chiang MT; Tsai DL; Li FA; Angata T; Crocker PR; Chau LY
J Biomed Sci; 2021 Jan; 28(1):5. PubMed ID: 33397354
[TBL] [Abstract][Full Text] [Related]
15. CKIP-1 limits foam cell formation and inhibits atherosclerosis by promoting degradation of Oct-1 by REGγ.
Fan J; Liu L; Liu Q; Cui Y; Yao B; Zhang M; Gao Y; Fu Y; Dai H; Pan J; Qiu Y; Liu CH; He F; Wang Y; Zhang L
Nat Commun; 2019 Jan; 10(1):425. PubMed ID: 30683852
[TBL] [Abstract][Full Text] [Related]
16. Requirement of JNK2 for scavenger receptor A-mediated foam cell formation in atherogenesis.
Ricci R; Sumara G; Sumara I; Rozenberg I; Kurrer M; Akhmedov A; Hersberger M; Eriksson U; Eberli FR; Becher B; Borén J; Chen M; Cybulsky MI; Moore KJ; Freeman MW; Wagner EF; Matter CM; Lüscher TF
Science; 2004 Nov; 306(5701):1558-61. PubMed ID: 15567863
[TBL] [Abstract][Full Text] [Related]
17. Endoplasmic reticulum stress promotes macrophage-derived foam cell formation by up-regulating cluster of differentiation 36 (CD36) expression.
Yao S; Miao C; Tian H; Sang H; Yang N; Jiao P; Han J; Zong C; Qin S
J Biol Chem; 2014 Feb; 289(7):4032-42. PubMed ID: 24366867
[TBL] [Abstract][Full Text] [Related]
18. IL-33 reduces macrophage foam cell formation.
McLaren JE; Michael DR; Salter RC; Ashlin TG; Calder CJ; Miller AM; Liew FY; Ramji DP
J Immunol; 2010 Jul; 185(2):1222-9. PubMed ID: 20543107
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Macrophage CD36 Expression and Cellular Oxidized Low Density Lipoprotein (oxLDL) Accumulation by Tamoxifen: A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR)γ-DEPENDENT MECHANISM.
Yu M; Jiang M; Chen Y; Zhang S; Zhang W; Yang X; Li X; Li Y; Duan S; Han J; Duan Y
J Biol Chem; 2016 Aug; 291(33):16977-89. PubMed ID: 27358406
[TBL] [Abstract][Full Text] [Related]
20. Eukaryotic elongation factor 2 kinase regulates foam cell formation via translation of CD36.
Fernando S; Salagaras T; Schwarz N; Sandeman L; Tan JTM; Xie J; Zareh J; Jensen K; Williamson A; Dimasi C; Chhay P; Toledo-Flores D; Long A; Manavis J; Worthington M; Fitridge R; Di Bartolo BA; Bursill CA; Nicholls SJ; Proud CG; Psaltis PJ
FASEB J; 2022 Feb; 36(2):e22154. PubMed ID: 35032419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
